| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/13/2008 | US20080280345 Screening Method |
| 11/13/2008 | US20080280320 Formulation of antigen |
| 11/13/2008 | US20080280318 Isolation and Culture of a High Purity Population of Cone Photoreceptor Cells by Tissue Dissociation and Pna-Panning, and Biological Applications Thereof |
| 11/13/2008 | US20080280317 Comprehensive Characterization Of Complex Proteins At Trace Levels |
| 11/13/2008 | US20080280316 Method of Detection, Separation and Identification for Expressed Trace Protein/Peptide |
| 11/13/2008 | US20080280311 Immunoassay for the Simultaneous Immunochemical Determination of an Analyte (Antigen) and a Treatment Antibody Targeting the Analyte in Samples (Recovery Immunoassay) |
| 11/13/2008 | US20080280310 Testing for Blood Group Immunological Reaction Without the Use of Anti-Human Globulin |
| 11/13/2008 | US20080280309 Monoclonal antibodies and uses thereof |
| 11/13/2008 | US20080280308 G protein coupled receptor signaling modulation |
| 11/13/2008 | US20080280307 Chimeric Recombinant Antigens of Toxoplasma Gondii |
| 11/13/2008 | US20080280306 Immunodiagnostic assay for quantifying proneurotensin concenrations in serums; diagnosing parkinson's, cell proliferative, gastrointestinal and respiratory system disorders |
| 11/13/2008 | US20080280305 Using transactivating (Tat) epitope 2 specific immunoglobulins to diagnose viral infection |
| 11/13/2008 | US20080280303 G-protein coupled receptors high-throughput functional assay |
| 11/13/2008 | US20080280302 Using angiopoietin 2, transmembrane protease, serine 4, extracellular matrix protein 1 biomarkers for cell proliferative disorders |
| 11/13/2008 | US20080280301 Using transmembrane serine protease expression as evaluative tool in detection of nervous system stem cells; regenerative medicine; tissue engineering; treating neurodegenerative |
| 11/13/2008 | US20080280300 Method |
| 11/13/2008 | US20080280298 Satb1: a determinant of morphogenesis and tumor metastasis |
| 11/13/2008 | US20080280297 Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia |
| 11/13/2008 | US20080280293 Method of Examining Inflammatory Disease and Method of Screening Remedy for Imflammatory Disease |
| 11/13/2008 | US20080280292 Oligonuceotide promers for non-symmetric polymerase chain reaction; gene expression analysis |
| 11/13/2008 | US20080280288 Assay Method to Predict Sensitivity of Cancer Cell to Anticancer Drug |
| 11/13/2008 | US20080280286 Compositions and Methods for Gene Expression |
| 11/13/2008 | US20080280285 Systems and Methods For Testing using Microfluidic Chips |
| 11/13/2008 | US20080280281 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 11/13/2008 | US20080279961 Telomere targeting agents as stem cells directed treatments |
| 11/13/2008 | US20080279893 Lawsonia intracellularis immunological proteins |
| 11/13/2008 | US20080279874 Compositions and methods for modulation of plk1 kinase activity |
| 11/13/2008 | US20080279872 Using dendritic cells expressing chymotrypsin protein fragment as immunostimulatory tool for targeting cancer cells associated with ovarian tissue |
| 11/13/2008 | US20080279870 ALK protein tyrosine kinase, cells and methods embodying and using same |
| 11/13/2008 | US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation |
| 11/13/2008 | US20080279849 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis |
| 11/13/2008 | US20080279847 Tumor-associated glycoprotein-72 specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 11/13/2008 | US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof |
| 11/13/2008 | US20080279831 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer |
| 11/13/2008 | US20080279814 Using interleukin-5 mixture as therapeutic tool in treatment of nervous system disorders |
| 11/13/2008 | US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders |
| 11/13/2008 | US20080279767 Cancerous disease modifying antibodies |
| 11/13/2008 | US20080279725 Multilayer Analytical Element |
| 11/13/2008 | US20080279723 Apparatus for quality control analysis of an on-site prepared pharmaceutical product |
| 11/13/2008 | US20080278731 Composite sensor membrane |
| 11/13/2008 | US20080278707 Cytological imaging system and method |
| 11/13/2008 | US20080277348 Exchanging liquids present around a magnetic substance; moving an exterior magnet so as to move the magnetic substance on the inner wall face of the vessel in order to take out the magnetic substance from the magnet |
| 11/13/2008 | US20080277294 Small Volume In Vitro Analyte Sensor |
| 11/13/2008 | US20080277293 system for determining the concentration of analyte in a biological fluid from a patient, comprising:at least one substrate associated with at least one transducer;a piercing member adapted to pierce a site on the patient to cause blood to flow therefrom;a sensor positioned adjacent to the site |
| 11/13/2008 | US20080277292 system for determining the concentration of analyte in a biological fluid from a patient, comprising:at least one substrate associated with at least one transducer;a piercing member adapted to pierce a site on the patient to cause blood to flow therefrom;a sensor positioned adjacent to the site |
| 11/13/2008 | US20080277291 system for determining the concentration of analyte in a biological fluid from a patient, comprising:at least one substrate associated with at least one transducer;a piercing member adapted to pierce a site on the patient to cause blood to flow therefrom;a sensor positioned adjacent to the site |
| 11/13/2008 | US20080277277 Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| 11/13/2008 | US20080276870 Milk conveyer device |
| 11/13/2008 | US20080276732 Indicator for orally administered compositions |
| 11/13/2008 | US20080276716 Penetration-type pipe strain gauge |
| 11/13/2008 | US20080276455 method of making an electrochemical sensor |
| 11/13/2008 | DE102008019880A1 Motor vehicle air conditioning, using carbon dioxide as a coolant, has a carbon dioxide sensor to register the carbon dioxide concentration within the vehicle to control the fan motor and sensor power supply |
| 11/13/2008 | DE102007041280B3 Concrete compression process monitoring arrangement, has display device provided for displaying measured sound levels at respective radiation places, and optical camera attached to sound camera |
| 11/13/2008 | DE102007022323A1 Multi-parameter measuring system for determining analytic parameter of e.g. blood, has physiochemical sensor either integrated into multi-parameter measuring device or connected with device as separate part over cable |
| 11/13/2008 | DE102007022224A1 Fuel's chemical and/or physical characteristics determining method for diesel-internal combustion engine, involves determining measure for chemical and/or physical characteristics of fuel from adjustment of combustion state |
| 11/13/2008 | DE102007021544A1 Messeinheit und Verfahren zur optischen Untersuchung einer Flüssigkeit auf eine Analytkonzentration Measuring unit and method for optically analyzing a liquid to an analyte concentration |
| 11/13/2008 | DE102007021443A1 Diagnose und Risikostratifizierung mittels NT-proET-1 Diagnosis and risk stratification using NT-1 proET |
| 11/13/2008 | CA2727939A1 Methods and compositions for use of cyclic analogues of histatin |
| 11/13/2008 | CA2723322A1 Methods for the detection of preeclampsia |
| 11/13/2008 | CA2686867A1 Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms |
| 11/13/2008 | CA2686638A1 Tnf.alpha. gene expression as a biomarker of sensitivity to antagonists of inhibitor of apoptosis proteins |
| 11/13/2008 | CA2686427A1 Method for the detection of specific immunoglobulin class g antibodies |
| 11/13/2008 | CA2686418A1 Multi-immunoaffinity based antigen identification |
| 11/13/2008 | CA2686381A1 Peptide standards |
| 11/13/2008 | CA2686376A1 Pharmaceutical analysis apparatus and method |
| 11/13/2008 | CA2686338A1 Method and device for non-invasive prenatal diagnosis |
| 11/13/2008 | CA2686211A1 Methods of screening for binding interaction using sets of microparticles and unique probes |
| 11/13/2008 | CA2686206A1 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies |
| 11/13/2008 | CA2686199A1 Detecting isomers using differential derivatization mass spectrometry |
| 11/13/2008 | CA2686039A1 Binding reagents that contain small epitope binding molecules |
| 11/13/2008 | CA2685896A1 Method for the diagnosis of tuberculosis by detecting an immune response to ompatb |
| 11/13/2008 | CA2685875A1 Methods and compositions for diagnosing osteoarthritis in a feline |
| 11/13/2008 | CA2684921A1 Method of detecting infection with urogenital mycoplasmas in humans and a kit for diagnosing same |
| 11/13/2008 | CA2684906A1 Cancerous disease modifying antibodies |
| 11/13/2008 | CA2684511A1 Pyridinium boronic acid quenchers for use in analyte sensors |
| 11/13/2008 | CA2684175A1 Methods and systems for detecting biological and chemical materials on a submicron structured substrate |
| 11/13/2008 | CA2681817A1 Lumber inspection method, device and program |
| 11/13/2008 | CA2679105A1 Devices and methods for detecting analytes |
| 11/13/2008 | CA2678641A1 Tandem mass spectrometry for detecting and/or screening for conditions associated with altered sterols |
| 11/12/2008 | EP1990641A1 Flow-through biosensor device |
| 11/12/2008 | EP1990639A1 System and method for real-time diagnosis, treatment, and therapeutic drug monitoring |
| 11/12/2008 | EP1990638A1 Flow-through biosensor |
| 11/12/2008 | EP1990428A1 Nucleic acid detection methods using universal priming |
| 11/12/2008 | EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 11/12/2008 | EP1990424A1 Polymorphic length of foxe 1 alanine stretch and genetic susceptibility to thyroid dysgenesis |
| 11/12/2008 | EP1990423A1 Method of determining the time to progression of non small cell lung cancer after chemotherapy based on thioredoxin expression |
| 11/12/2008 | EP1990422A1 Pyruvate-kinase as a novel target molecule |
| 11/12/2008 | EP1990421A1 Method for detection of condition in consciousness disorder patient and kit for the detection |
| 11/12/2008 | EP1990415A1 Osteoprotegerin |
| 11/12/2008 | EP1990413A1 Screening method for candidate drugs |
| 11/12/2008 | EP1990350A1 Marker for mesenchymal stem cells and its use |
| 11/12/2008 | EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment |
| 11/12/2008 | EP1990057A1 Beta-secretase substrates and uses thereof |
| 11/12/2008 | EP1989939A1 Oasis gene-deficient mouse |
| 11/12/2008 | EP1989556A2 Essays for ischemia |
| 11/12/2008 | EP1989555A1 The use of natriuretic peptides and placenta growth factor levels for risk stratification of individuals elected for cardiac stress testing |
| 11/12/2008 | EP1989554A1 Methods and kit for diagnosing t1dm |
| 11/12/2008 | EP1989553A1 Metabonomic methods to assess health of skin |
| 11/12/2008 | EP1989552A1 Protein markers for diagnosing stomach cancer and the diagnostic kit using them |
| 11/12/2008 | EP1989551A2 Method of detecting or diagnosing of a neurodegenerative disease or condition |